Paul T. Quinlan, General Counsel: CymaBay Therapeutics CBAY Sell · Filed 24/01/16

Trade details

Type: Insider sale
Amount: $117,900
Shares · price: 5,000 sh · $23.58 a share
Held after: 0 sh
Stock: CymaBay Therapeutics CBAY
Person: Paul T. QuinlanGeneral Counsel
Trade date: 24/01/16
Filed: 24/01/16
Days to filing: 0 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

CymaBay Therapeutics trades, last 26 weeks

What else happened in CymaBay Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/17~24/02/15

Paul T. Quinlan's recent trades

Paul T. QuinlanGeneral Counsel
Planned sale10b5-1 planOruka Therapeutics
Planned sale10b5-1 plan
Oruka Therapeutics
ORKA
$7.7M
71,000 sh
$7.7M
Filed 08/14
Traded 08/14
Paul T. QuinlanGeneral Counsel
SellOruka Therapeutics
Sell
Oruka Therapeutics
ORKA
$51.1K
733 sh
$51.1K
Filed 06/15
Traded 06/15
Paul T. QuinlanGeneral Counsel
SellOruka Therapeutics
Sell
Oruka Therapeutics
ORKA
$30.3K
733 sh
$30.3K
Filed 03/17
Traded 03/16
Paul T. QuinlanGeneral Counsel
SellCymaBay Therapeutics
Sell
CymaBay Therapeutics
CBAY
$109.9K
5,000 sh
$109.9K
Filed 23/12/15
Traded 23/12/15
Paul T. QuinlanGeneral Counsel
SellCymaBay Therapeutics
Sell
CymaBay Therapeutics
CBAY
$86.9K
5,000 sh
$86.9K
Filed 23/11/17
Traded 23/11/15